Stay updated on Insulin Degludec Titration in Mobile Insulin Dosing System Clinical Trial
Sign up to get notified when there's something new on the Insulin Degludec Titration in Mobile Insulin Dosing System Clinical Trial page.

Latest updates to the Insulin Degludec Titration in Mobile Insulin Dosing System Clinical Trial page
- Check3 days agoChange DetectedThe page shows a minor revision bump from v3.3.3 to v3.3.4 in the template metadata; no changes to core study information, eligibility criteria, primary/secondary outcomes, or enrollment data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedDifference0.4%

- Check39 days agoChange DetectedRemoved the condition 'Type 2 Diabetes' and the related topic 'MedlinePlus Genetics' from the page.SummaryDifference0.2%

- Check53 days agoChange DetectedFooter revision updated to v3.3.2, replacing v3.2.0, a minor system change that does not affect study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check60 days agoChange DetectedThe page no longer displays the banner about a lapse in government funding and related operating status. All study details and eligibility criteria remain unchanged.SummaryDifference0.4%

- Check75 days agoChange DetectedThe two screenshots show the same study details (NCT03091712) with only minor visual/layout differences; no additions or deletions to core content were detected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Insulin Degludec Titration in Mobile Insulin Dosing System Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Insulin Degludec Titration in Mobile Insulin Dosing System Clinical Trial page.